Search Results
Results found for "Kevin Wright"
- Addex and Indivior Extend GABAB Positive Allosteric Modulator Research Collaboration for...
The reserved indications, where Addex retains exclusive rights to develop its own independent GABAB PAM program, have also been expanded to include chronic cough, in addition to the rights to develop certain
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
Originally developed as ultra-bright lanthanide probes, the team realized they could tune these molecules Dual control: not just brightness but fluorescence lifetime, with drastic shifts as pH drops.
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
Those who act on the right signals today will lead tomorrow’s breakthroughs—and avoid delays others won between stalled programs and breakthrough therapies often lies in a single insight delivered at the right
- Integrating Fluorescent Ligands into Flow Cytometry: Enhancing GPCR Analysis Beyond Traditional Antibody Staining
. - High-throughput applications Bright and stable fluorescent ligands can be used in HTS, Tag brightness and stability: the brighter and more stable the better the assay outcome. 2.
- Obesity-induced changes in human islet G protein-coupled receptor expression: Implications for ...
and, in this review, we have compared expression of GPCR mRNAs in human islets obtained from normal weight range donors, and those with a weight range classified as obese.
- The Truth About GPCR Product Launches: Years in the Making
But a pattern emerged: some scaffolds showed dual responsiveness to pH through lifetime and brightness lanthanide probe design with Durham University (chemistry) → Discovery of pH-sensitive dual response (brightness
- Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?
My work isn't just about the latest and best assay; it's about the framework that ensures the right assay data leads to the right decision.
- Signals in Motion: Pain, Metabolism & Terry’s Corner
Novo Nordisk’s amycretin showed up to 24% weight loss, CagriSema delivered 22.7% in Phase 3, and semaglutide
- New Tools, Smart Signals, and The Kenakin Brief
GIPR biased agonism enhances metabolic outcomes —with dual targeting showing synergistic glucose and weight
- Targeting GPCRs in the CNS: Advances in Drug Discovery Strategies
Advantages of Fluorescent Ligands in GPCR Drug Screening for CNS Choosing the right tools is important for the success of drug discovery, just as much as choosing the right targets.
- Identification of hub genes in the subacute spinal cord injury in rats
The differentially expressed genes (DEGs) and weighted correlation network analysis (WGCNA) were performed
- From Venice to Virtual Molecules: Alessandro Nicoli’s Unexpected Journey into Computational Chemistry
But one academic spark—and the right mentor—changed his trajectory forever.
- The Quiet Power of RGS Proteins: Rethinking Pain Pathways through GPCR Biology
... and honestly, like with the trials, they were not really that sufficiently better than opioids, right
- Why Kinetics Matter More Than Kd in GPCR Drug Discovery
GPCR Premium is designed for scientists who need the right intelligence, fast—without noise, distractions Those acting on the right signals today will shape tomorrow’s breakthroughs—and avoid delays others won
- Pharmacology at Your Fingertips: Terry’s Corner Launches
inbox every Thursday, follow these simple steps: Select the Log In / Sign Up option located at the top right
- Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota..
Moreover, independent of glucose control or weight loss, the anti-inflammatory actions of GLP-1RAs require
- Novel Therapies for Cardiometabolic Disease: Recent Findings in Studies with Hormone...
strategy is the so-called metabolic surgery whose beneficial effects are beyond dietary restrictions and weight
- How a Failed Experiment Created a Powerful GPCR Imaging Tool
Drug efficacy depends on which cells express the receptor Side effects are tied to where agonists bind Weight-loss
- Regulation of rod photoreceptor function by farnesylated G-protein γ-subunits
Bright illumination triggered Gαt1 translocation from the rod outer to inner segments in all three transgenic
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024
That's right, you're about to level up your knowledge game! keep you on your toes Direct line to all the cool cats in the GPCR community - Networking is key, right
- High-Content Screening for GPCR Programs: Overcoming Assay Limitations with Fluorescent Ligands
Overcoming them requires careful assay design and strategic use of the right fluorescent probes. CB 2 -expressing HEK cell lines are labeled with CELT-331 at 80 nM (right), while competition with the
- 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024
accidental discoveries could revolutionise women’s health Seven unanswered questions about blockbuster weight-loss
- Involvement of various chemokine/chemokine receptor axes in trafficking and oriented locomotion ...
Chemokines are low molecular weight proteins that their functional activities are achieved by binding
- Applications of Fluorescent Probes in Confocal Imaging of GPCRs: From Live to Fixed Cells
Right panel, the fluorescent signal is displaced when, after incubating with CELT-327, cells are incubated
- Why “Displacement” Misleads You: Allosteric Binding Demystified
translational strategy, this is where 40 years of pharmacological insight meets the questions you’re asking right
- From Farm Fields to GPCR Discovery, GLP-1 and GIP
How do we prevent lean muscle loss during weight loss?
- Fluorescence Polarization in GPCR Research
New generations of fluorophores with improved photostability and brightness will enhance assay sensitivity
- How Schild Analysis Protects Your Conclusions in GPCR Research
Acting on the right signals today shapes tomorrow’s breakthroughs — and prevents delays others won’t
- Irreversible Drugs, Real Control: Design for Durable Target Engagement
GPCR innovation is accelerating; act on the right signals today to shape tomorrow’s breakthroughs—and
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
Those acting on the right signals today will shape tomorrow’s breakthroughs—and avoid delays others won























